Related Experiment Videos

Termination of pacemaker-mediated tachycardia by adenosine

J B Conti1, A B Curtis, J A Hill

  • 1University of Florida College of Medicine, Division of Cardiology, Gainesville 32610-0277.

Clinical Cardiology
|January 1, 1994
PubMed

Insights

This case study shows adenosine can stop pacemaker-mediated tachycardia (PMT) by blocking signals between heart chambers. Reprogramming the pacemaker also prevented further PMT episodes in a heart transplant patient.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Cardiac transplantation patients may require pacemakers for bradycardia.
  • Pacemaker-mediated tachycardia (PMT) is a potential complication of pacemaker use.

Observation:

  • A 30-year-old heart transplant recipient experienced pacemaker-mediated tachycardia during cardiac catheterization.
  • The tachycardia presented as rapid ventricular pacing with capture.
  • Intravenous adenosine administration successfully terminated the episode.

Findings:

  • Adenosine effectively broke the pacemaker-mediated tachycardia by inducing ventriculoatrial block.
  • Reprogramming the pacemaker to specific AV delay and postventricular atrial refractory periods resolved the issue.
  • This demonstrates adenosine's utility in acute PMT management.

Implications:

  • Intravenous adenosine is a viable option for terminating pacemaker-mediated tachycardia.
  • Pacemaker reprogramming is crucial for long-term prevention of PMT.
  • Understanding PMT mechanisms is vital for managing cardiac transplant patients with pacemakers.

Related Concept Videos